MIB Agents Awards $100,000 Grant for Pediatric Osteosarcoma Research at MD Anderson

MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for its community of patients, caregivers, doctors, and researchers, has awarded a $100,000 research grant to Andy Livingston, M.D., a clinician and researcher in Sarcoma Medical Oncology and in Pediatric Oncology at The University of Texas MD Anderson Cancer Center. Ann Graham, Founder and Executive Director of MIB Agents, and Christina Ip-Toma, MIB Agents’ Director of Scientific Programs, presented the award to Dr. Livingston on Dec. 1 in Houston.

AES Clean Technology launches OMNI™ Electric Utility Raceway

This latest product is an innovative power and data management system that reduces risk and accelerates cleanroom delivery for the life sciences and pharmaceutical industry.

REFERENCE MATERIALS FOR CALIBRATION VERIFICATION TESTING OF CHOLESTEROL ASSAYS NOW AVAILABLE FROM VERICHEM

Emplicure AB and Quotient Sciences Announce an Integrated Manufacturing and Clinical Testing Partnership for Emplicure’s First Clinical Pharmacokinetic Study for EMPLI03

Quotient Sciences, a global drug development and manufacturing accelerator, today announced a partnership with Emplicure, a Swedish pharmaceutical company focused on chronic pain and abuse-deterrent formulations.

Foundational partnership with Paradigm4 enables Alnylam Pharmaceuticals to rapidly accelerate RNAi- based drug target discovery

The Mobile Health/Central Lab Interface, an opportunity for DCT efficiency

The Mobile Health/Central Lab Interface, an opportunity for DCT efficiency How streamlining relations between central labs and mobile health providers can get the most from hybrid and decentralised clinical trials

Upgrading to FFP3 face masks in hospitals could save the NHS £360m a year and help slash patient waiting lists

The NHS could save up to £360M per year by using FFP3 face masks – the NHS already has a large stockpile of these masks so there is no current need to purchase more. Independent studies commissioned by PPE manufacturer Globus Group and carried out by York Economic Health Consortium and Vital Economics confirm that these masks may be better at preventing respiratory infection and resulting staff days off.

CD ComputaBio Introduces PyMOL Software for Bioinformatics Analysis

Pronalyse’s Fusion Protein Characterization Service Aids in the Drug Development Process

Creative Proteomics Lipidomics Launches Ceramides Analysis Service

Creative Proteomics Metabolomics Unveils Drug-Resistant Metabolomics Research Service

VisualDx partners with Emergence Health to support urgent care clinicians with diagnosis and treatment decisions

VisualDx has teamed up with Emergence Health Holdings, an urgent care network across New England, to grant its providers access to AI-fueled assistive technology to support diagnosis and treatment. Amid concurrent crises, staff shortages, and other challenges in medicine, VisualDx is collaborating with an array of organizations to arm clinicians with tech that helps them do their jobs better, faster, and more accurately. In addition to Emergence, the company also recently teamed up with the Vermont Department of Health, HHS’s Biomedical Advanced Research and Development Authority, and the American College of Emergency Physicians to help clinicians diagnose and treat everything from Covid to Monkeypox, polio, the flu, and more.

Biopharma PEG Develops PEG Products For Click Chemistry

Andelyn Biosciences to Manufacture First Gene Therapy for Infantile Neuroaxonal Dystrophy in the US

Huateng Pharma Supplies Semaglutide Intermediates Against Type 2 Diabetes

Genezen appoints Chief Commercial Officer to Executive Leadership Team

Genezen appoints Jeff Whitmore as Chief Commercial Officer

uMotif Announces First New Validated Innovation in eCOA/ePRO Since Paper Instruments Were Deployed on Smartphones

Patent-protected Motif data capture interface from uMotif was proven as an equivalent method to capture Patient Reported Outcome and eDiary data, eliminates reliance on text-based instruments, in a study with 55 participants in 2 randomized groups conducted by SAFIRA Clinical Research at Dublin City University.

Creative Enzymes Expands Its Service Offering with the Launch of Custom Enzyme Blends

Creative Enzymes Provides DNA Molecular Weight Markers and Ladders

CD Genomics Expands Its Sequencing Portfolio with the Launch of Whole Exome Sequencing